Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Carasent AB ( (SE:CARA) ) has shared an update.
Carasent AB will publish its interim report for the first quarter of 2026 on 14 April at 07:00 CET, as the healthtech group continues its regular financial reporting to investors and other stakeholders. The timing of the release positions the company ahead of the main Nordic reporting window, giving the market an early read on its start to the year.
Management will present the results in a live webcast at 08:00 CET the same day, underscoring the company’s focus on accessibility and transparency for shareholders. Investors can also join via teleconference with the option to ask verbal questions, which may provide additional insight into Carasent’s short-term performance and strategic priorities.
The most recent analyst rating on (SE:CARA) stock is a Hold with a SEK24.50 price target. To see the full list of analyst forecasts on Carasent AB stock, see the SE:CARA Stock Forecast page.
More about Carasent AB
Carasent AB is a Sweden-based public company active in the digital health and healthtech sector, providing software and digital solutions primarily for healthcare and care providers. The group focuses on cloud-based platforms and services that support clinical workflows, administration and patient management for customers across the Nordic region and selected European markets.
Average Trading Volume: 139,141
Technical Sentiment Signal: Hold
Current Market Cap: SEK1.6B
Find detailed analytics on CARA stock on TipRanks’ Stock Analysis page.